Klogene Therapeutics, Inc. and Kogenix Therapeutics, Inc. today announced the merger of the two companies. The combined company, using the name Klogene, is focused on Klotho, a naturally occurring pleiotropic human protein that has been shown to have potential therapeutic effects in neurodegenerative diseases such as Alzheimer's as well as kidney disease, certain cancers, and more. Higher...Read the full story at https://pressreleasejet.com/news/klogene-and-kogenix-announce-merger.html